Cargando…

Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK

BACKGROUND: We aimed to estimate and externally validate a new UK-specific prognostic model for predicting the long-term risk of a first recurrent event (local recurrence, metastatic recurrence, or second primary breast cancer) in women diagnosed with early breast cancer. METHODS: Using data on the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campbell, H E, Gray, A M, Harris, A L, Briggs, A H, Taylor, M A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2010
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2966633/ https://www.ncbi.nlm.nih.gov/pubmed/20823886 http://dx.doi.org/10.1038/sj.bjc.6605863

Ejemplares similares

External validation of three prognostic models for overall survival in patients with advanced-stage epithelial ovarian cancer
por: van de Laar, R, et al.
Publicado: (2014)

Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer
por: Lee, C K, et al.
Publicado: (2011)

An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom
por: Campbell, H E, et al.
Publicado: (2009)

Compliance with guidelines is related to better local recurrence-free survival in ductal carcinoma in situ
por: de Roos, M A J, et al.
Publicado: (2005)

Development and Validation of a Prognostic Nomogram for Postoperative Recurrence-Free Survival of Ameloblastoma
por: Yang, Yao-Cheng, et al.
Publicado: (2021)

Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy
por: Tian, Y-M, et al.
Publicado: (2014)

Nomogram for Predicting Recurrence-Free Survival in Chinese Women with Endometrial Cancer after Initial Therapy: External Validation
por: Cheng, Yuan, et al.
Publicado: (2020)

External Validation of a Prognostic Score for Survival in Lung Carcinoids
por: Chiappetta, Marco, et al.
Publicado: (2022)

Prognostic Factors and Survival in Patients Treated Surgically for Recurrent Metastatic Uterine Leiomyosarcoma
por: Hoang, Han L. T., et al.
Publicado: (2014)

The impact of organisational external peer review on colorectal cancer treatment and survival in the Netherlands
por: Kilsdonk, M J, et al.
Publicado: (2014)

A web-based prognostic tool for extremity and trunk wall soft tissue sarcomas and its external validation
por: Sampo, M, et al.
Publicado: (2012)

Carboplatin–paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer
por: Lee, C K, et al.
Publicado: (2011)

Health care costs for the treatment of breast cancer recurrent events: estimates from a UK-based patient-level analysis
por: Karnon, J, et al.
Publicado: (2007)

BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers
por: Lee, Y-K, et al.
Publicado: (2009)

Innovative estimation of survival using log-normal survival modelling on ACCENT database
por: Chapman, J W, et al.
Publicado: (2013)

An external validation study of nomograms designed to predict isolated loco-regional and distant endometrial cancer recurrences: how applicable are they?
por: Bendifallah, S, et al.
Publicado: (2013)

Predicting Infectious ComplicatioNs in Children with Cancer: an external validation study
por: Haeusler, Gabrielle M, et al.
Publicado: (2017)

External validation of a prognostic model to predict survival of patients with sentinel node‐negative melanoma
por: Ipenburg, N. A., et al.
Publicado: (2019)

Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST)
por: Nilsson, B, et al.
Publicado: (2007)

External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry
por: Veldhuijzen van Zanten, Sophie E. M., et al.
Publicado: (2017)

Validated preoperative computed tomography risk estimation for postoperative hepatocellular carcinoma recurrence
por: Zhang, Wei, et al.
Publicado: (2017)

Estimating progression-free survival in patients with glioblastoma using routinely collected data
por: Kelly, Charlotte, et al.
Publicado: (2017)

External validation of the modified Glasgow prognostic score for renal cancer
por: Tai, Caroline G., et al.
Publicado: (2014)

External validation of multidimensional prognostic indices (ADO, BODEx and DOSE) in a primary care international cohort (PROEPOC/COPD cohort)
por: Espantoso-Romero, Maite, et al.
Publicado: (2016)

Development and external validation of predictive models for prevalent and recurrent atrial fibrillation: a protocol for the analysis of the CATCH ME combined dataset
por: Chua, Winnie, et al.
Publicado: (2019)

External validation of the Bayesian Estimated Tools for Survival (BETS) models in patients with surgically treated skeletal metastases
por: Forsberg, Jonathan Agner, et al.
Publicado: (2012)

Development and external validation of a novel nomogram model for predicting postoperative recurrence-free survival in non-muscle-invasive bladder cancer
por: Ding, Li, et al.
Publicado: (2022)

External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes
por: van Dieren, S., et al.
Publicado: (2010)

Prognostic factors for disease-free survival in postoperative patients with hepatocellular carcinoma and construction of a nomogram model
por: Luo, Pan-Quan, et al.
Publicado: (2022)

Derivation and Validation of a New Equation for Estimating Free Valproate Concentration in Critically Ill Adult Patients
por: Liu, Ji Tong, et al.
Publicado: (2023)

Multicentre external validation of IOTA prediction models and RMI by operators with varied training
por: Sayasneh, A, et al.
Publicado: (2013)

External validation of risk prediction models for incident colorectal cancer using UK Biobank
por: Usher-Smith, J A, et al.
Publicado: (2018)

Assessing the external validity of model-based estimates of the incidence of heart attack in England: a modelling study
por: Scarborough, Peter, et al.
Publicado: (2016)

External validation of a prognostic index
por: Bonnett, Laura, et al.
Publicado: (2013)

Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma
por: Gu, Jing-Xian, et al.
Publicado: (2019)

The Prognostic Factors of Biochemical Recurrence-Free Survival Following Radical Prostatectomy
por: Chalieopanyarwong, Virote, et al.
Publicado: (2017)

How do we estimate survival? External validation of a tool for survival estimation in patients with metastatic bone disease—decision analysis and comparison of three international patient populations
por: Piccioli, Andrea, et al.
Publicado: (2015)

Brain metastases free survival differs between breast cancer subtypes
por: Berghoff, A, et al.
Publicado: (2012)

External Validation of the Dutch SOURCE Survival Prediction Model in Belgian Metastatic Oesophageal and Gastric Cancer Patients
por: van Kleef, J.J., et al.
Publicado: (2020)

Correction: External validation of risk prediction models for incident colorectal cancer using UK Biobank
por: Usher-Smith, J. A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3vea51qqnovd211g3hd4el6f4e